Global Bio CMO Market: Size, Trends & Forecasts 2016-2021: Key Companies are Lonza, Boehringer Ingelheim & Samsung Electronics (Samsung Biologics) - Researchmoz

Researchmoz added Most up-to-date research on "Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)" to its huge collection of research reports.

The report entitled Global Bio CMO Market: Size, Trends & Forecasts (2016-2021), provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global bio CMO market has been forecasted for the years 2016-2021, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=948217

Lonza, Boehringer Ingelheim, Samsung Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done
in the report, which includes business overview, financial overview and respective business strategies of the companies.

Company Coverage

Lonza
Boehringer Ingelheim
Samsung Electronics (Samsung Biologics)

Executive Summary

Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. Worlds largest pharmaceutical firms are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The global bio CMO market is supported by various growth drivers, such as increase in pharmaceutical industry, growth in use of biosimilars, potential biologics blockbusters, etc. Yet, the market faces certain challenges, such as risk associated with CMOs, presence of in-house manufacturing facilities of big pharma companies, productivity issues with mammalian cell system, etc.

Table Of Content

1. Executive Summary

2. Introduction
2.1 Pharmaceutical Industry Overview
2.1.1 Segments of Pharmaceutical Industry (Drugs)
2.2 Biotechnology/Biologics Overview
2.3 Biosimilar Overview
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview

3. Global Market Analysis

3.1 Global Biologics Market: An Analysis
3.1.1 Global Biologics Market by Value
3.1.2 Global Biologics Market by Top Selling Drugs
3.1.3 Global Biologics Market by Product in Development
3.1.4 Global Biologics Manufacturing market by Value

3.2 Global Bio CMO Market: An Analysis
3.2.1 Global Bio CMO Market by Penetration Rate
3.2.2 Global Bio CMO Market by Value
3.2.3 Global Bio CMO Market by Capacity
3.2.4 Global Bio CMO Market by Segments

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Global Pharmaceutical Market Growth
4.1.2 Potential Biologics Blockbusters
4.1.3 Increase in Biosimilar Market
4.1.4 Preference of Biologics Over Small Molecules

4.2 Challenges
4.2.1 Presence for In-House Biopharma Manufacturing
4.2.2 Risk Associated with CMOs
4.2.3 Productivity Issue with Mammalian Cell System

4.3 Market Trends
4.3.1 Big Pharmaceuticals Outsourcing Rate
4.3.2 Capacity Utilization Rate of CMOs
4.3.3 Growth in Mammalian Cell Structure
4.3.4 Stringent Regulatory Requirements for Biologics and Biosimilars

5. Competitive Landscape

5.1 Global Bio CMO Market by Number of Firms
5.2 Global Bio CMO Market Players by Capacity

6. Company Profiling

6.1 Lonza
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy

6.2 Boehringer Ingelheim
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy

6.3 Samsung Electronics (Samsung Biologics)
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=948217

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.